206 related articles for article (PubMed ID: 9499104)
1. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Mathew E; Sanderson CM; Hollinshead M; Smith GL
J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
Herrera E; Lorenzo MM; Blasco R; Isaacs SN
J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
[TBL] [Abstract][Full Text] [Related]
3. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
Rodger G; Smith GL
J Gen Virol; 2002 Feb; 83(Pt 2):323-332. PubMed ID: 11807225
[TBL] [Abstract][Full Text] [Related]
4. A mutational analysis of the vaccinia virus B5R protein.
Mathew EC; Sanderson CM; Hollinshead R; Smith GL
J Gen Virol; 2001 May; 82(Pt 5):1199-1213. PubMed ID: 11297695
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
Lorenzo MM; Herrera E; Blasco R; Isaacs SN
Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
Wolffe EJ; Isaacs SN; Moss B
J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
[TBL] [Abstract][Full Text] [Related]
7. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
8. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
Roper RL; Wolffe EJ; Weisberg A; Moss B
J Virol; 1998 May; 72(5):4192-204. PubMed ID: 9557708
[TBL] [Abstract][Full Text] [Related]
9. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
Katz E; Wolffe EJ; Moss B
J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
[TBL] [Abstract][Full Text] [Related]
10. An investigation of incorporation of cellular antigens into vaccinia virus particles.
Krauss O; Hollinshead R; Hollinshead M; Smith GL
J Gen Virol; 2002 Oct; 83(Pt 10):2347-2359. PubMed ID: 12237415
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
McIntosh AA; Smith GL
J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Parkinson JE; Smith GL
Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
[TBL] [Abstract][Full Text] [Related]
14. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
15. Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
Roper RL; Moss B
J Virol; 1999 Feb; 73(2):1108-17. PubMed ID: 9882312
[TBL] [Abstract][Full Text] [Related]
16. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
17. Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively.
Borrego B; Lorenzo MM; Blasco R
J Gen Virol; 1999 Feb; 80 ( Pt 2)():425-432. PubMed ID: 10073703
[TBL] [Abstract][Full Text] [Related]
18. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
Mathew EC; Sanderson CM; Hollinshead R; Hollinshead M; Grimley R; Smith GL
Virology; 1999 Dec; 265(1):131-46. PubMed ID: 10603324
[TBL] [Abstract][Full Text] [Related]
19. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.
Lorenzo MM; Galindo I; Griffiths G; Blasco R
J Virol; 2000 Nov; 74(22):10535-50. PubMed ID: 11044098
[TBL] [Abstract][Full Text] [Related]
20. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.
Ward BM; Moss B
J Virol; 2001 May; 75(10):4802-13. PubMed ID: 11312352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
